Table 3. The effect of top ranking metabolites significantly associated with T2D on insulin sensitivity and insulin secretion during follow-up.
Metabolite | Traits (dependent variable) | Non-T2D cases (N = 104) |
T2D cases (N = 96) |
||||||
---|---|---|---|---|---|---|---|---|---|
β | Lower 95% CI | Higher 95% CI | P† | β | Lower 95% CI | Higher 95% CI | P† | ||
Indolepropionic acid | Matsuda ISI | 0.13 | −0.17 | 0.43 | 0.39 | 0.03 | −0.22 | 0.27 | 0.83 |
DI30 | 0.25 | 0.06 | 0.44 | 0.01 | −0.04 | −0.30 | 0.21 | 0.73 | |
LPC(17:0) | Matsuda ISI | 0.21 | 0.01 | 0.41 | 0.04 | 0.23 | −0.02 | 0.47 | 0.07 |
DI30 | 0.05 | −0.15 | 0.25 | 0.60 | 0.15 | −0.11 | 0.40 | 0.26 | |
LPC(19:0) | Matsuda ISI | 0.13 | −0.07 | 0.33 | 0.20 | 0.12 | −0.13 | 0.36 | 0.35 |
DI30 | −0.04 | −0.24 | 0.16 | 0.69 | 0.07 | −0.18 | 0.33 | 0.56 | |
LPC(20:1) | Matsuda ISI | 0.23 | 0.03 | 0.43 | 0.02 | −0.01 | −0.28 | 0.27 | 0.97 |
DI30 | −0.01 | −0.21 | 0.19 | 0.91 | 0.15 | −0.13 | 0.43 | 0.28 | |
PC(22:6/18:2) | Matsuda ISI | 0.21 | 0.01 | 0.40 | 0.04 | −0.12 | −0.36 | 0.12 | 0.31 |
DI30 | 0.02 | −0.18 | 0.22 | 0.82 | 0.05 | −0.20 | 0.30 | 0.69 | |
PC(18:1/22:6) | Matsuda ISI | 0.15 | −0.05 | 0.35 | 0.14 | −0.05 | −0.29 | 0.20 | 0.71 |
DI30 | −0.17 | −0.36 | 0.03 | 0.10 | 0.19 | −0.06 | 0.44 | 0.13 | |
LPC(15:1) | Matsuda ISI | 0.26 | 0.07 | 0.46 | 0.01 | 0.08 | −0.17 | 0.32 | 0.54 |
DI30 | 0.09 | −0.11 | 0.30 | 0.37 | 0.05 | −0.24 | −0.34 | 0.73 | |
PC(20:4/17:0) | Matsuda ISI | −0.04 | −0.24 | 0.16 | 0.68 | −0.02 | −0.27 | 0.22 | 0.85 |
DI30 | 0.03 | −0.17 | 0.23 | 0.75 | 0.01 | −0.24 | 0.27 | 0.92 | |
PC(22:6/17:0) | Matsuda ISI | −0.07 | −0.27 | 0.13 | 0.48 | 0.01 | −0.23 | 0.26 | 0.91 |
DI30 | −0.16 | −0.35 | 0.04 | 0.12 | 0.17 | −0.09 | 0.42 | 0.19 | |
PC(15:1/18:2) | Matsuda ISI | 0.32 | 0.13 | 0.51 | 0.001 | 0.25 | −0.01 | 0.51 | 0.06 |
DI30 | 0.17 | −0.03 | 0.36 | 0.10 | 0.00 | −0.27 | 0.27 | 0.99 | |
LPE(16:0) | Matsuda ISI | 0.06 | −0.14 | 0.26 | 0.57 | −0.11 | −0.36 | 0.15 | 0.40 |
DI30 | 0.03 | −0.17 | 0.23 | 0.79 | −0.07 | −0.33 | 0.20 | 0.61 | |
PC(18:2/15:0) | Matsuda ISI | 0.09 | −0.11 | 0.30 | 0.37 | 0.14 | −0.12 | 0.40 | 0.29 |
DI30 | 0.15 | −0.05 | 0.36 | 0.14 | 0.19 | −0.08 | 0.45 | 0.16 | |
L-Phenylalanine | Matsuda ISI | −0.23 | −0.42 | −0.04 | 0.02 | −0.26 | −0.49 | −0.02 | 0.04 |
DI30 | −0.07 | −0.27 | 0.13 | 0.48 | 0.04 | −0.22 | 0.29 | 0.78 | |
Tyrosine | Matsuda ISI | −0.36 | −0.55 | −0.17 | 2.7 × 10−4 | −0.40 | −0.63 | −0.16 | 0.001 |
DI30 | −0.12 | −0.32 | 0.08 | 0.23 | 0.06 | −0.20 | 0.32 | 0.66 | |
Alanine | Matsuda ISI | −0.08 | −0.27 | 0.12 | 0.45 | −0.03 | −0.31 | 0.25 | 0.82 |
DI30 | 0.17 | −0.02 | 0.37 | 0.08 | 0.13 | −0.15 | 0.42 | 0.35 | |
Proline | Matsuda ISI | −0.18 | −0.38 | 0.02 | 0.08 | −0.08 | −0.32 | 0.17 | 0.53 |
DI30 | −0.14 | −0.34 | 0.06 | 0.18 | 0.09 | −0.15 | 0.34 | 0.45 | |
Isoleucine | Matsuda ISI | −0.27 | −0.46 | −0.08 | 0.006 | −0.28 | −0.53 | −0.03 | 0.03 |
DI30 | −0.01 | −0.21 | 0.19 | 0.90 | 0.02 | −0.24 | 0.29 | 0.87 |
*Non-T2D cases mean of 7 years (up to 14 years). T2D cases up to 5 years.
†For ANCOVA models testing the effect of each metabolite on either one of the traits (dependent variable), adjusted for study group (fixed factor). Averaged measurements are calculated as: mean of years 2,3,4 and 5 in T2D cases and mean of years 2, 3, 4, 5 and 7 in non-T2D cases. ISI: insulin sensitivity index DI30: disposition index.